Kirsten Marie Kliphouse
Known title: DirectorCIK: 0001948684
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Transaction History
| GPN | ▲ Buy | Grant | 3,179 | $0 | 5/1/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 897 | — | 2/11/2026 | View on chart |
| GPN | ▲ Buy | Grant | 3,173 | $0 | 4/25/2025 | View on chart |
| LH | ▲ Buy | Option Exercise | 944 | — | 2/6/2025 | View on chart |
| GPN | ▲ Buy | Grant | 1,846 | $0 | 4/26/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 947 | — | 2/7/2024 | View on chart |
| GPN | ▲ Buy | Grant | 878 | $92K | 10/26/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 372 | — | 10/12/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BofA reinstates Global Payments coverage with $114 target
Bank of America has restarted coverage on Global Payments, issuing a buy rating and a price target of $114. This move places the stock within a broader wave of analyst actions affecting the payments sector, which also saw updates for FIS and Toast. The new target sits above the current average analyst estimate of $105.34, signaling renewed institutional interest in the company's outlook.
BofA reinstates Global Payments coverage with $114 target. Bank of America has restarted coverage on Global Payments, issuing a buy rating and a price target of $114. This move places the stock within a broader wave of analyst actions affecting the payments sector, which also saw updates for FIS and Toast. The new target sits above the current average analyst estimate of $105.34, signaling renewed institutional interest in the company's outlook.